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Abstract
Background: The unique photonic properties of the recently developed fluorescent
semiconductor nanocrystals (QDs) have made them a potential tool in biological research.
However, QDs are not yet a part of routine laboratory techniques. Double and triple
immunocytochemistries were performed in HeLa cell cultures with commercial CdSe QDs
conjugated to antibodies. The optical characteristics, due to which QDs can be used as
immunolabels, were evaluated in terms of emission spectra, photostability and specificity.
Results: QDs were used as secondary and tertiary antibodies to detect β-tubulin (microtubule
network), GM130 (Golgi complex) and EEA1 (endosomal system). The data obtained were
compared to homologous Alexa Fluor 594 organic dyes. It was found that QDs are excellent
fluorochromes with higher intensity, narrower bandwidth values and higher photostability than
Alexa dyes in an immunocytochemical process. In terms of specificity, QDs showed high specificity
against GM130 and EEA1 primary antibodies, but poor specificity against β-tubulin. Alexa dyes
showed good specificity for all the targets tested.
Conclusion: This study demonstrates the great potential of QDs, as they are shown to have
superior properties to Alexa dyes. Although their specificity still needs to be improved in some
cases, QDs conjugated to antibodies can be used instead of organic molecules in routine
immunocytochemistry.
Background
Semiconductor nanocrystals called Quantum Dots (QDs)
are fluorochromes with many advantages compared to the
organic fluorescent dyes habitually used in immunocyto-
chemistry procedures [1]. Their water solubility and
capacity to be conjugated with different biomolecules
have only recently been established [2]; therefore, their
application in both the biological and medical research
fields is still scarce.
Since the first microscope appeared up to the present day,
different kinds of dyes (fluorescent proteins, small fluo-
rescent molecules, etc.) have been used to detect or local-
ize different biomolecules within an intracellular context.
Published: 27 May 2009
Journal of Nanobiotechnology 2009, 7:4 doi:10.1186/1477-3155-7-4
Received: 5 March 2009
Accepted: 27 May 2009
This article is available from: http://www.jnanobiotechnology.com/content/7/1/4
© 2009 Montón et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 10
(page number not for citation purposes)
Journal of Nanobiotechnology 2009, 7:4 http://www.jnanobiotechnology.com/content/7/1/4In the last decade, when nanotechnology became rele-
vant, QDs were introduced as a promising methodologi-
cal tool due to their intrinsic brightness, high
photostability, high molar extinction coefficient, narrow
emission band, and excitability with several wavelengths
[3]. These qualities opened the possibility to handle sam-
ples labeled with different colors, preventing fluorescent
signal crossing-over, using a single laser line to excite dif-
ferent QDs at the same time [4].
QDs are aggregates of atoms -from hundreds to tens of
thousands that behave as one- of semiconductor materials
that produce a crystalline matrix (nanocrystal). Composi-
tion, size and shape of this matrix determine their physi-
cal characteristics. The properties of nanocrystals vary
according to their size, which ranges generally from 1 to
10 nm in diameter [5]; whereas smaller QDs emit in
shorter wavelengths, bigger QDs emit in longer wave-
lengths. The crystalline core of QDs is composed of cad-
mium selenide and covered with a zinc sulfide shell.
Moreover, some QDs are coated with different kinds of
polymers and molecules in order to make them water-sol-
uble and to facilitate their conjugation to different bio-
molecules, providing a specific functionality [6-9].
QDs can be linked to many molecules, such as DNA, pro-
teins and antibodies, and therefore they have a wide range
of applications in the biosciences. To date, QDs have been
used to localize proteins [10,11] and mRNA within the
cell [12], to label cancer markers [13], to follow in vivo
metastatic cells during extravasation [14] or to track
embryonic stem cells in deep tissues [15].
The aim of this study was to use QDs as secondary and ter-
tiary antibodies in a routine immunocytochemistry proce-
dure in which organic dyes are currently used. Therefore,
we characterized the shape, size and optical properties of
QD 655 (IgG or streptavidin conjugated) in order to
develop a standard protocol for protein immunodetec-
tion using QDs. We have made a comparative study of flu-
orescence intensity, bandwidth, photostability, specificity
and the quality of QD 655 versus its homologous organic
fluorophore, Alexa 594 (IgG or streptavidin conjugated),
to evaluate the possibility of replacing Alexa with QDs in
this protein detection procedure.
Results
QDs characterization by HRTEM
QD 655 showed a cone-like shape (Figure 1) with no dif-
ferences in shape between QDs conjugated to streptavidin
or to IgG. However, when comparing the size of the QDs
conjugated to IgG with those conjugated to streptavidin,
significant differences (p < 0.05) were found. QD 655-IgG
is bigger (15.4 ± 0.2 × 6.4 ± 0.1 nm) than QD 655-strep
(13.1 ± 2.8 × 6.3 ± 0.9 nm).
QDs characterization by CLSM
QDs have been reported to present several optical advan-
tages in fluorescence detection regarding conventional
organic fluorophores. QD 655 has been compared to
Alexa 594 to evaluate differences in fluorescence intensity,
bandwidth, photostability and specificity.
Spectra emission
First, the maximum fluorescence emission peak (λem) of
both fluorophores was assessed using the lambdascan
function of the CLSM. QD 655 presented its maximum at
651 nm, whereas Alexa 594 had its peak at 615 nm (Figure
2, Table 1). The λem value recorded was identical for the
same fluorophore independently of its conjugation (IgG
or strep).
Second, the fluorescence intensity (FI) level of QD 655 (Ig
or Strep) and Alexa 594 (Ig or strep) was calculated. The
FI level of QD 655 was higher than that of Alexa 594
(Table 1).
Differences in bandwidth, calculated from the emission
profiles (Figure 2), were also found when both kinds of
fluorophores were compared. QDs had narrower values of
bandwidth than the homologous Alexas (Table 1).
Photostability
Photostability was assessed by exposing immunolabeled
cultures for eight minutes at the maximum power laser
line of 561 nm. For the first 90 seconds, the initial fluores-
cence intensity of β-tubulin labeled with QD 655s was
reduced by about 5%. The same laser incidence produced
an intensity reduction of 90% in cultures labeled with
Alexa 594s. At the end of the irradiation period, no β-
tubulin was detected in cultures labeled with Alexa 594s,
whereas in cultures labeled with QD 655s, β-tubulin still
kept up to 10%–40% of the initial fluorescence intensity
(Figure 3 and 4).
Staining specificity
Staining specificity was analyzed on cell cultures labeled
with primary antibody against the microtubule network
(β-tubulin), Golgi complex (GM130) or endosomal sys-
tem (EEA1). Brightness of both fluorophores conjugated
to IgG was similar (Figure 5). Differences in specificity
were detected when QD 655-IgG was used as a secondary
antibody against β-tubulin. The network of microtubules
was not well defined, with background and QD aggregates
that had not selectively linked to β-tubulin. In contrast,
Alexa 594-IgG was very specific and the microtubule net-
work was definitely detectable. When QDs and Alexas
were used as tertiary antibodies, the tubulin network was
clearly detected by both fluorophores, but Alexa fluoro-
chromes were more specific in pinpointing the tubulin fil-
ament structure. No differences in specificity werePage 2 of 10
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ary or tertiary antibody against GM130 or EEA1. Both
types of fluorophores showed similar specificity (Figure
6).
Discussion
In this work inorganic QDs were used to demonstrate
their feasibility and advantages as a basic research tech-
nique in routine immunocytochemistry, as compared to
Alexa organic dyes. To our knowledge, commercial QDs
are not yet standardized; neither are they completely char-
acterized to be used without further evaluation [16,17].
HRTEM characterization of QDs demonstrated differ-
ences in core size between the two types of QDs. In theory,
these differences should be due to QD manufacturing, but
the current methods used to produce QD allow particle
size and particle size distribution to be controlled accu-
rately [18]. Moreover, according to the Quantum Dot Cor-
poration [2], there are only slight size differences in a
given batch of QDs. However, other authors have found
some variability in CdSe QDs size distribution [19].
One of the optical properties measured was the emission
spectrum, which in QDs is related to their size. QD 655
conjugated to IgG or streptavidin displays a higher emis-
sion peak and a narrower bandwidth than its Alexa homo-
logue. These advantageous characteristics have been well
documented previously by different authors [4,13,20]
and offer the possibility of using different QDs simultane-
ously without overlapping emission bands. The band-
width of our batch of QD 655 (IgG and strep) was similar
to that described in the literature [18,20].
Slight differences in size result in slight variations in the
emission wavelength. As a consequence, the emission
spectrum of a certain nanocrystal ensemble will be
broader than an individual QD spectrum [21]. A variation
in size distribution of 5% translates into a bandwidth of
approximately 25–30 nm, a narrow value compared to
the bandwidth of many fluorescent dyes [21]. Since the
size distribution of each QD analyzed in this study was
about 10%, it was expected that the bandwidth would be
greater (ca. 35 nm).
Another optical characteristic analyzed was the intrinsic
brightness of both fluorophores. The fluorescence inten-
sity (FI) was higher in QDs than in Alexas. Most authors
agree that QDs have superior brightness than organic
fluorophores [1,13,20,22]. However, other studies have
found that QDs are not as bright as expected [23]. Slight
differences in FI (ca. 8%) were detected between both
QDs, while in Alexas these differences were inappreciable.
Other authors have found that the FI of QD 525-IgG was
nearly one-third that of QD 525-streptavidin [24].
Photostability was the third optical property analyzed,
and the entire scientific community agrees that this is the
best advantage of QDs, as compared to other fluorescent
dyes [3,5]. Our study confirms that QDs have the highest
photostability. This characteristic is very important when
in vivo analyses are carried out and long-term experiments
are necessary and use multiple targets [25]. But photosta-
bility is also a determining factor in fixed samples in
which some magnification is needed to find the best reso-
lution to observe subcellular structures. Before QDs came
out, Alexa dyes were considered to be the most photosta-
ble fluorophores [26]. Nowadays, this reality has
changed: Alexa fluorophores lose almost all of their fluo-
rescence in only 90 seconds of laser exposure, while we
have demonstrated that QDs can be exposed to laser light
for eight consecutive minutes and less than 40% of their
initial fluorescence is lost.
All of these characteristics confirm that QDs have unique
optical properties that make them powerful fluorescent
dyes. In addition to the increasing interest in QDs in fluo-
rescence techniques, their electron-dense core has poten-
HRTEM QD characterizationFigure 1
HRTEM QD characterization. The large image shows a 
general view of QD 655 dispersion. The small image shows a 
detail of a single QD 655 cone-like nanocrystal. Its crystalline 
structure core can be seen. Scale bar = 10 nm.Page 3 of 10
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TEM, which would allow protein localization inside cells
on a nanometric scale [11]. However, there is some con-
troversy regarding the specificity of QDs as immunola-
bels. While some authors argue that QDs have
comparable or even superior specificity in relation to
organic fluorophores [27], others consider that QDs are
appropriate fluorophores to be used as immunolabels,
although without increasing sensitivity, and with higher,
non-specific binding and aggregation than Alexa dyes
[18,23]. Low specificity could be due to different reasons:
i) a non-optimal concentration of QDs that could lead to
a non-specific signal [1], or ii) a non-optimal surface
chemistry of QDs that would affect their spectroscopic
properties and colloidal stability as well as their biomo-
lecular function or size, which could sterically hamper
access to cellular targets [20]. Several authors have
pointed out the importance of QD concentration for
improving the sensitivity of detecting water pathogens
[22], as well as improving specific immunostaining [1].
Before starting the QD characterization, we tested three
different concentrations of QD 655 in order to use the
most appropriate in which to perform this study (data not
shown). The optimal concentration was 30 nM because
there were scarce aggregates and the QD concentration
was high enough to label the tubulin network.
On the other hand, specificity was higher when QDs were
used as a tertiary antibody, but still lower compared to
their Alexa homologue. Other authors have reported that
QD sensibility is improved when they are used as tertiary
antibodies [24]; this increase in sensibility is probably due
to the high affinity between streptavidin and biotin, and
to the signal amplification.
Finally, the specificity of QDs in detecting β-tubulin,
GM130 and EEA1 proteins was tested. While specificity
Fluorescence emission spectraigure 2
Fluorescence emission spectra. Spectral profile representing fluorescence intensity versus emission wavelength (500–780 
nm) for QD 655-IgG, QD 655-Streptavidin and their Alexa homologues. Excitation wavelength = 488 nm.
Table 1: Spectral properties.
Emission peak (nm) FIa Bandwidth (nm)b
Q655-IgG 651 200 35.5
Q655-strep 651 180 37
A594-IgG 615 75 48
A594-strep 615 75 53
Emission peak, fluorescence intensity (FI) and bandwidth for QD 655 
and Alexa 594 analyzed at 488 nm excitation wavelength.
(a) Values in gray level (0–255).
(b) Calculated as the full width at 50% maximum of the emission 
spectrum (FWHM) in the FI profile.Page 4 of 10
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were observed when QDs were used to stain the Golgi
complex (GM130 protein) or endosomes (EEA1). Specif-
icity of QDs was higher for primary antibodies against
proteins like GM130 and EEA1, which are scarce in the
cell and are not involved in the composition of thin struc-
tures. Specificity was lower for proteins such as β-tubulin
which is an abundant protein in the cell and that polym-
erizes producing an extremely well organized thin struc-
ture. QD 655 is one of the largest QDs commercialized,
and it is possible that its size could sterically obstruct its
access to its target [20].
Conclusion
QDs are excellent fluorophores for labeling cellular tar-
gets, as they display higher intensity, an enhanced signal
to noise ratio, a narrower bandwidth and higher photosta-
bility than organic dyes. However, the specificity of QDs
depends on the target they have to bind to. More studies
are needed to improve the specificity of QDs so they can
be used routinely, alone or in combination with organic
fluorescent dyes, in all biological applications. In this
study we were able to use QDs as secondary and tertiary
antibodies to clearly detect discrete localized proteins.
Therefore, in these cases, they can replace fluorescent
organic molecules in routine immunocytochemistry pro-
cedures.
In the future, when better control of the synthesis and
functionalization of QDs is possible, the range of biolog-
ical applications of these fluorophores can be extended
and they can become part of basic research techniques.
Materials and methods
Material
Two types of red emission spectra QDs were used as sec-
ondary and tertiary antibodies: QD 655 Goat F(ab)2 anti-
mouse IgG conjugate (QD 655-IgG) and QD 655 strepta-
Photostability profileFigure 3
Photostability profile. Fluorescence intensity changes of QDs and Alexas during the irradiation period with the 561 nm 
laser line at maximum power.Page 5 of 10
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emission Alexa Fluor Dyes: Alexa 594 Goat F(ab)2 anti-
mouse IgG conjugate (Alexa 594-IgG) and Alexa 594
streptavidin conjugate (Alexa 594-strep) were used to
compare to QD antibodies. Secondary antibodies QD
655-IgG and Alexa 594-IgG were purchased from Molecu-
lar Probes (Invitrogen Corp; Eugene, Oregon, USA), and
Anti-Ms IgG biotin from Boheringer (Mannheim; Indian-
apolis, USA). Primary antibody monoclonal anti-β-tubu-
lin was purchased from Sigma-Aldrich Chemie GmbH
(Steinheim, Germany). GM130 and EEA1 primary anti-
bodies were purchased from BD Biosciences (San Jose,
California, USA).
High Resolution Transmission Electron Microscopy 
(HRTEM)
To carry out a HRTEM analysis, 0.5 μl of each QD was
diluted in 500 μl of MilliQ water and centrifuged for 10
minutes at 6000 rpm to eliminate all organic precipitates.
A drop of each diluted QD was deposited on a carbon
layer copper grid and air-dried.
Images of each type of QD were obtained with a HRTEM,
using a JEOL JEM 2011 transmission electron microscope
(Jeol LTD; Tokyo, Japan) operating at 200 kV. The sizes of
the QDs were determined with Digital Micrograph soft-
ware (Gatan Inc; Warrendale, Pennsylvania, USA) and
data obtained were processed with statistics software Ori-
gin-8 (OriginLab Corporation; Northampton, Massachu-
setts, USA).
CLSM photostability imagesFigure 4
CLSM photostability images. Left-hand images correspond to the emission signal of QDs and Alexas conjugated to strepta-
vidin before the irradiation period (t = 0 min) with the 561 nm laser line at its maximum power. Right-hand images show the 
emission signal of QDs and Alexas at the end of the irradiation period (t = 8 min). Note the loss of fluorescence intensity in the 
delimited area. Scale bar = 10 μm.Page 6 of 10
(page number not for citation purposes)
Journal of Nanobiotechnology 2009, 7:4 http://www.jnanobiotechnology.com/content/7/1/4Cell cultures
Two different culture cell lines, Vero (ATCC-CCL-81) and
HeLa (ATCC-CCL-2), were used. Cells were maintained in
MEM (GIBCO, Rockville, Maryland, USA) supplemented
with 10% Fetal Calf Serum (GIBCO) and incubated at
37°C and 5% CO2 in a humidified atmosphere.
Immunocytochemistry
For immunocytochemistry analysis, cells were seeded
onto glass coverslips and incubated at 37°C and 5% CO2,
until confluence was reached. Cells were fixed in 4% para-
formaldehyde (Electron Microscopy Sciences; Fort Wash-
ington, Pennsylvania, USA) in 0.01 M phosphate buffer
saline (Sigma Aldrich Chemie GmbH; Steinheim, Ger-
many) for 15 min, permeabilized in 0.25% Triton X-100
(Fluka Chemie AG; Buchs, Switzerland) for 15 min and
blocked in 6% bovine serum albumin (Sigma Aldrich
Chemie GmbH; Steinheim, Germany) for 40 min. Finally,
cells were incubated with the anti-β-tubulin monoclonal
antibody (4 μg/ml) to detect the microtubule network,
with the GM130 antibody (10 μg/ml) to detect the Golgi
complex or with the EEA1 antibody (2.5 μg/ml) to detect
the endosomal system. In all cases the primary antibody
was incubated for 1 h at 37°C.
To perform secondary immunodetection, anti-Ms IgG
antibody conjugated to Alexa or QDs (4 μg/ml and 30 nM
final concentration, respectively) was used. For tertiary
immunodetection, cells were first incubated with Anti-Ms
IgG Biotin (1 μg/ml) for 1 h at 37°C, and then with
CLSM specificity analysis of β-tubulin labelingFigure 5
CLSM specificity analysis of β-tubulin labeling. Maximum intensity projections of the distribution of the tubulin network 
labeled with QDs (top images) show lower specificity than their organic Alexa homologue labeling (bottom images). Scale bar 
= 10 μm.Page 7 of 10
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CLSM specificity analysis of GM130 and EEA1 labelingFigure 6
CLSM specificity analysis of GM130 and EEA1 labeling. Isosurface representation of the cell shows the nucleus (blue) 
labeled with Hoechst 33342, Golgi complex (GM130) and endosomal system (EEA1) (red) within a three-dimensional volumet-
ric x-y-z data field. Scale bar = 10 μm.
Journal of Nanobiotechnology 2009, 7:4 http://www.jnanobiotechnology.com/content/7/1/4streptavidin conjugated to Alexa or QDs (4 μg/ml and 30
nM final concentration, respectively). Coverslips were
mounted onto glass slides using Fluoprep mounting
media (bioMérieux® SA, Marcy l'Etoile, France) to preserve
fluorescence.
Confocal Laser Scanning Microscopy (CLSM)
Images were captured with a CLSM Leica TCS-SP5 AOBS
spectral (Leica Microsystems Heidelberg GmbH; Man-
nheim, Germany) using a Plan-Apochromatic 63× objec-
tive (NA 1.4, oil).
Series of images (xyλ), called lambdastacks, were taken to
determine the spectra emission of QDs and Alexas and to
establish their bandwidth. The excitation wavelength used
was the 488 nm line of an Ar laser. The AOTF was set at
40% and 80% for QDs and Alexas, respectively.
The emission detection was set from 500 to 780 nm. The
confocal pinhole for each lambdastack was fixed at 2 Airy
units. For each xy focal plane, confocal microscopy meas-
ured the emission variation every 10 nm (lambda step size
= 7 nm). The emission spectra analysis was processed
using the CLSM software (Leica LAS AF). A Region of
Interest (ROI) was delimited to determine the fluores-
cence intensity (FI) in the selected area in relation to the
wavelength. To analyze immunolabeled cells, 45 ROIs of
2 μm2 were selected near cell nuclei; FI and bandwidth
were calculated in the selected ROIs.
Photostability experiments were performed using the Live
Data Mode function of the CLSM, which permits monitor-
ing long time-lapse experiments. Each type of fluorophore
was illuminated with a 561 nm excitation laser line for 8
minutes (100% power, zoom = 6). Images were taken at 1
second intervals, in 512 × 512 pixels with 8 bits of
dynamic range. In the area where the laser was at its max-
imum illumination power, 45 ROIs of 2 μm2 were
selected to show the FI in the region in relation to time.
Secondary or tertiary antibody specificity was evaluated
using the xyz mode of the CLSM, which permits one to
scan the xy plane along the z axis. Images were captured
every 0.2 μm along 3 μm of thickness, with 1 Airy confocal
pinhole. From the xyz series obtained by CLSM, maxi-
mum intensity projections were achieved with Leica LAS
AF software, and three-dimensional models were gener-
ated using Imaris software (Bitplane; Zürich, Switzer-
land).
Statistical analysis
To determine if there were significant differences in size
between QDs conjugated to IgG or to streptavidin, a two-
sample T-Student's test (T-test) for comparison of means,
with 95% confidence, was carried out. Previously, a F-
Fisher test was performed and equal variances were
assumed due to the returned p-value of 0.389. The equal-
ity of means hypothesis was rejected when the p-value was
lower than 0.05 (p < 0.05).
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